Private Label Retinol Glycolic Acid Eye Cream — Low MOQ

The minimum order quantity for private label retinol eye cream typically starts at 200–500 units for a stock or semi-custom formula, and 500–2,000 units for a fully custom development. Several factors push MOQs up or allow them to stay low. Fill format is a major driver. Airless pump tubes and glass rollerballs often have higher component MOQs (sometimes 1,000 pieces per SKU from the component supplier), which forces the finished-goods MOQ up even if the manufacturer is willing to fill fewer units. Sachets and generic white-label tubes are usually the most flexible starting points for sub-500-unit runs. Active concentration affects MOQ indirectly. Retinol is photosensitive and requires nitrogen-blanketed mixing, light-exclusion packaging, and careful cold-chain storage. Manufacturers who have invested in that infrastructure often charge a minimum batch fee — commonly $800–$2,500 — rather than a per-unit MOQ. A $1,500 batch fee at $7/unit effective cost implies 215 units just to break even on the run setup, so even a '200-unit MOQ' manufacturer may have implicit higher floors. Regulatory market matters too. If you need EU-compliant labelling with a Safety Assessment (CPSR) and an ophthalmologist-tested claim, manufacturers need to run a larger batch to amortise the cost of third-party testing. For EU-only launches, 500 units is a more realistic low-MOQ floor. For US-only white-label launches with generic packaging, 200–300 units is genuinely achievable. For a differentiated formula with custom packaging and dual-market (US + EU) compliance, plan for 500–1,000 units minimum. The mistake most first-time founders make is negotiating MOQ in isolation. A manufacturer who agrees to 200 units but then requires you to buy 1,000 airless pumps, 1,000 outer cartons, and 1,000 labels has effectively imposed a 1,000-unit commitment through the component supply chain. Always get a full BOM (bill of materials) quote before locking in your MOQ agreement. AJ Cosmo Labs lets you filter manufacturers on the platform by stated MOQ so you only engage partners whose minimums align with your launch volume from the start.

The total landed cost of a private label retinol glycolic acid eye cream depends on four stacked cost layers: formula + filling, primary packaging, secondary packaging (cartons, inserts), and compliance testing. Formula and filling at low MOQ (200–1,000 units) typically runs $5–$18 per unit. The wide range reflects active concentrations (retinol at 0.1% vs 0.3% and glycolic acid at 2% vs 5% meaningfully affect raw-material cost), fill weight (a 15ml eye cream costs less to fill than a 30ml), and whether you're using a stock formula or a custom development. Custom formulas often carry a one-time development fee of $1,500–$5,000 on top of per-unit costs. Primary packaging adds $1.50–$6.00 per unit at low volumes. Airless pumps in glass or high-end plastic sit at the top of that range; aluminium tubes or simple plastic squeeze tubes sit at the bottom. Eye cream pen applicators with a metal tip are popular for the periorbital area but cost $2.50–$5.00 each at 500 units. Secondary packaging (printed carton, insert card, tamper-evident seal) adds $0.50–$2.00 per unit at low MOQ. At 500 units, carton printing is expensive relative to larger runs — expect $0.80–$1.50 per unit for a simple two-colour carton. Full-colour rigid boxes push that to $2.00–$4.00. Compliance and testing costs are often the most surprising to new founders. A US HRIPT and ocular irritation study for an 'ophthalmologist-tested' claim runs $2,000–$6,000. EU CPSR preparation adds $800–$2,500. Accelerated stability testing (12 weeks minimum) is often bundled by the manufacturer but can add $500–$1,500 if outsourced. Challenge (preservative efficacy) testing runs $300–$600. Total cost-to-launch for a 500-unit run of a white-label retinol glycolic acid eye cream with stock formula, decent packaging, and US compliance is realistically $8,000–$15,000 all in. A fully custom formula with EU compliance and premium packaging at 500 units can reach $20,000–$35,000. At 2,000 units, per-unit economics improve significantly — formula + filling typically drops to $4–$10, and packaging costs fall as component suppliers give better pricing above 1,000-unit thresholds. Always request an itemised quote from any manufacturer that separates raw materials, labour, packaging, testing, and any NDA or formula exclusivity fees. Use the AJ Cosmo Labs app to collect multiple itemised quotes in one place so you can compare like for like.

From initial brief to finished goods in hand, a private label retinol glycolic acid eye cream typically takes 8–24 weeks, depending on whether you're using a stock formula or commissioning custom development. For a stock formula programme, the timeline breaks down roughly as follows: brief and NDA sign-off (1–2 weeks), formula selection and sample production (2–3 weeks), sample review and approval (1–2 weeks), label and packaging artwork approval (1–3 weeks), bulk production scheduling and raw-material procurement (2–4 weeks), filling and QC (1–2 weeks), and shipping to your warehouse (1–2 weeks domestic, 3–5 weeks if importing internationally). Total: 9–16 weeks under normal conditions. For a custom formula, add a formulation and iteration phase of 4–10 weeks before any stability testing begins. Accelerated stability testing alone requires a minimum of 12 weeks (3 months at 40°C/75% RH per ICH guidelines, or the manufacturer's equivalent protocol). Some manufacturers run stability in parallel with early packaging design to compress the overall timeline, but you cannot skip or shorten this phase if you intend to substantiate shelf-life claims or sell into the EU. Ophthalmologist testing or HRIPT (Human Repeat Insult Patch Test) for claim support adds 6–8 weeks and must typically be completed on the final formula — meaning it runs after formulation is locked. The most common timeline killers are: artwork revision loops (founders underestimate how many rounds of label proofing occur), raw-material lead times for speciality retinol esters or encapsulated retinol (which can have 6–10 week lead times from API suppliers), and late payment of deposits that cause the manufacturer to release your production slot. For a realistic launch plan: allow 16 weeks minimum for a stock formula with simple packaging, and 28–32 weeks if you're doing custom development, EU compliance, and ophthalmologist testing from scratch. Building your brief and communicating timelines clearly to manufacturers from day one is critical. The AJ Cosmo Labs app lets you attach timeline requirements directly to your brief so manufacturers self-select based on their current capacity.

Yes, retinol and glycolic acid can be combined in the same eye cream, but the formulation challenge is significant and many low-quality stock formulas get it wrong — which is why asking your manufacturer specifically about their pH management approach is essential due diligence. The core tension is pH. Retinol (pure vitamin A alcohol) and retinol esters like retinyl palmitate or retinyl acetate are stable across a wider pH range (roughly pH 4.5–7), whereas retinal and retinaldehyde are more sensitive. Glycolic acid is most biologically active at pH 3.0–4.0 but requires a pH above 3.5 in periorbital products to minimise irritation risk for sensitive eye-area skin. A well-formulated combination product typically lands at pH 4.0–5.0 — a narrow window that requires precise buffering, usually with sodium hydroxide or triethanolamine, and careful monitoring throughout the fill run. Encapsulated retinol (liposomal or microencapsulated) is a popular solution for combination formulas because the encapsulation protects the retinol from the low-pH glycolic acid environment until the capsules rupture on skin contact. This approach allows a lower overall formula pH without sacrificing retinol stability, and it's particularly common in eye cream applications where you want both actives to function. The periorbital skin is thinner and more sensitive than the rest of the face, which introduces additional formulation constraints. Glycolic acid concentration is typically kept at 2–5% for eye area use (vs. up to 10–12% for face exfoliants), and the formula should avoid known sensitisers, heavy fragrance, and high concentrations of alcohols. Efficacy-wise, the combination does work synergistically in the research literature: glycolic acid exfoliates and may enhance penetration of retinol into the dermis, while retinol stimulates collagen synthesis and accelerates cell turnover. For anti-ageing eye cream positioning, this is a strong and defensible active combination. From a regulatory standpoint, in the EU the combination in a leave-on periorbital product must comply with both the retinol concentration cap (0.3% in face products as of 2025 guidance) and the glycolic acid labelling requirements (sun-protection advisory at concentrations above 3% AHA). A competent cosmetic chemist — the kind you'll find through AJ Cosmo Labs — should be able to navigate both constraints simultaneously.

For a retinol glycolic acid eye cream, the minimum credible certification set from a contract manufacturer is ISO 22716:2007 (GMP for cosmetics). This is the internationally recognised standard governing premises, personnel, production, quality control, and documentation. In the US, MoCRA (effective 2024–2025 phase-in) requires facility registration with the FDA, and ISO 22716 GMP is the practical standard that underpins that compliance. Do not work with any manufacturer who cannot produce their ISO 22716 certificate on request — and verify it hasn't lapsed. For the EU market, ISO 22716 is a prerequisite, but you also need to confirm the manufacturer can supply — or help you source — a Responsible Person (RP) service and a full Cosmetic Product Safety Report (CPSR) prepared by a qualified EU safety assessor. Some US manufacturers have RP partnerships in the EU; others don't, and you'll need to arrange this separately. Without a CPSR, your product cannot legally be sold in the EU. For claims substantiation, relevant third-party certifications and studies include: HRIPT (Human Repeat Insult Patch Test) for hypoallergenic or dermatologist-tested claims, ophthalmologist-tested protocols for periorbital products, and clinical efficacy studies (conducted by a CRO) if you want to support claims like 'reduces fine lines in 4 weeks.' These are not manufacturer certifications per se, but the manufacturer must be willing and equipped to produce samples for third-party testing. If you intend to market organic or natural claims, look for manufacturers certified under COSMOS, ECOCERT, or NATRUE. However, note that certified-organic formulations at low pH with glycolic acid are technically challenging because many synthetic chelators and preservatives used to stabilise acidic eye cream formulas are not COSMOS-approved. A truly COSMOS-certified retinol–glycolic acid eye cream is rare and will command a significant cost premium. For the US, Prop 65 compliance (California) should be confirmed for the full formula — not just the actives but also packaging materials like printing inks and closures, which can introduce listed chemicals. A responsible manufacturer will have a Prop 65 statement for their standard packaging components. Finally, if you're selling into professional or clinical channels (spas, aesthetic clinics, dermatologist offices), some buyers will ask for ISO 9001 in addition to ISO 22716, and may request Certificate of Analysis (CoA) documents for every batch. Confirm your manufacturer issues batch-level CoAs with pH, viscosity, and microbial testing results. AJ Cosmo Labs vets manufacturers for certifications before they're listed on the platform, so you can filter by certification type when you post your brief through the iOS app.

Finding a US-based private label eye cream manufacturer willing to work at low MOQ requires more than a Google search — the publicly listed directories often mix brokers, inactive companies, and manufacturers whose true minimums are far higher than advertised. The most effective approaches are: specialised B2B platforms that pre-vet manufacturers (rather than general directories), trade shows like Cosmoprof North America or MakeUp in LA where you can meet technical sales reps face-to-face, and referrals from other indie founders in online communities. Of these, B2B platforms with verification layers save the most time because the pre-qualification is already done. When evaluating a US manufacturer specifically for a retinol glycolic acid eye cream, confirm the following in your first outreach: (1) Do they have a validated stock formula or experience custom-developing low-pH active formulas for the periorbital area? (2) What is their true stated MOQ for a 15ml airless pump eye cream, and does that MOQ include or exclude packaging components? (3) Can they supply a Certificate of Analysis with pH and microbial data for every batch? (4) Do they offer accelerated stability testing in-house or outsource it, and who bears the cost at low volumes? (5) Are they registered with the FDA under MoCRA? US manufacturers with a genuine low-MOQ capability for speciality actives are more common on the coasts — California (particularly LA and the Bay Area) and New Jersey/New York have the highest density of cosmetic contract manufacturers with active-ingredient expertise. Midwest and Southeast manufacturers exist but tend to specialise in higher-volume personal care rather than prestige actives. Turnaround times from US manufacturers are generally faster than from Asian manufacturers for low MOQ runs — 8–14 weeks vs. 12–20 weeks — because raw-material procurement, production, and shipping are all domestic. However, US manufacturing typically commands a 20–40% per-unit cost premium over comparable South Korean or European facilities at the same volume. The AJ Cosmo Labs iOS app was built to solve exactly this problem: post your retinol glycolic acid eye cream brief, specify your MOQ, preferred geography, and timeline, and receive responses from pre-screened US (and international) manufacturers. Download it from the App Store to start sourcing today.

To get an accurate, actionable quote from a contract manufacturer for a private label retinol glycolic acid eye cream, you need to provide a clear brief that covers seven areas. Vague briefs result in vague quotes — and the quoted price often balloons once the manufacturer uncovers details you didn't mention upfront. First, target formula profile: specify that you want a retinol + glycolic acid eye cream, state the preferred concentration ranges (e.g., retinol 0.1–0.3%, glycolic acid 3–5%), any additional actives you want (peptides, niacinamide, caffeine, hyaluronic acid), and any ingredients you want excluded (fragrance-free, paraben-free, sulfate-free, etc.). If you have a reference product whose texture, finish, or colour you want to approximate, name it or describe it. Second, fill weight and format: eye creams typically range from 10ml to 30ml. Specify the fill volume and the primary container type you want — airless pump, squeeze tube, glass jar, pen applicator, or rollerball. If you don't have a strong preference, say so and ask for their recommendation at your MOQ. Third, MOQ and volume forecast: state the quantity you need for your first order and your projected volume at 6 and 12 months. Manufacturers use this to decide whether to quote custom development costs or steer you to a stock formula. Fourth, regulatory market: tell them where you plan to sell — US only, US + EU, US + Canada, global. This determines labelling requirements, INCI format, safety documentation, and whether you need a Responsible Person service for the EU. Fifth, claims: list the marketing claims you intend to make (anti-ageing, reduces fine lines, firms skin, ophthalmologist-tested, hypoallergenic, fragrance-free, vegan, cruelty-free). Each claim has documentation implications that affect the quote. Sixth, packaging design status: let them know whether you have final artwork ready, are still in design, or need referrals to packaging designers. Many manufacturers will delay quoting finalised tooling and label costs until artwork is at least 80% complete. Seventh, timeline: state your target launch date and work backwards. If you need product in hand in 16 weeks, say so upfront — some manufacturers will decline if their current capacity can't meet the date rather than overpromise. With all seven of these elements in your brief, a credible manufacturer can return a detailed itemised quote within 5–10 business days. Posting this brief through the AJ Cosmo Labs app ensures it reaches multiple verified manufacturers simultaneously, so you're comparing real quotes rather than waiting on one response at a time.